pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›FLUOROURACIL
drug
save

FLUOROURACIL

Preclinicalupdated 3mo ago
by Sisaf Ltd
Preclinical
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval132 co-mentions · 66 sources
  • drugFAVLYXA73 co-mentions · 72 sources
  • drugEfudex72 co-mentions · 72 sources
  • companyFresenius Kabi USA LLC12 co-mentions · 12 sources
  • drugRNS-6012 co-mentions · 12 sources
  • tagOncology5 co-mentions · 2 sources
  • companyTianjin Medical University Cancer Institute and Hospital1 co-mentions · 1 sources
  • companyTehran University of Medical Sciences1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying FLUOROURACIL

  • phase3A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinomarecruitingn=900
  • phase1A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumorsterminatedn=226
  • phase3A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)recruitingn=477
  • phase3Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )recruitingn=670
  • phase1A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)recruitingn=830
  • phase3A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancerrecruitingn=500
  • phase1A Study of ASP3082 in Adults With Advanced Solid Tumorsrecruitingn=681
  • phase2A Study of MRG007 Combination Therapy for Advanced Colorectal Cancernot yet recruitingn=316
more trials →

News(1)

  • Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
    Deirdre J. Cohen, MD, MS, discusses clinical decision-making and the comparative efficacy of FOLFIRINOX and NALIRIFOX in metastatic pancreatic cancer.
    onclive · 3mo ago
brand
FLUOROURACIL
generic
FLUOROURACIL
indication
Hypertrophic Scars
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 29m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?